It is administered via subcutaneous injection, though oral formulations are also being studied
The combination of GPX4 inhibitors with immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis increases the proportion of CD8 + T cells, enhances their cytotoxic activity and induces ferroptosis, thereby promoting chemotherapy resistance [42]
Obstruccin intestinal : Se han descrito casos de leo paraltico y obstruccin intestinal funcional relacionados con el efecto del GLP-1 sobre el vaciado gstrico y la motilidad intestinal
Ayoub E, Lehotzky D, Li L, Muftuoglu M, Nishida Y, Mohanty V, Leighton JS, Patsilevas T, Basyal M, Bedoy A, Haftarah T, Takahashi K, Chen K, Navin N, Issa GC, Getz G, Andreeff M
glp-1 manufacturing drug manufacturing GLP-1 Drug Manufacturing: Expansion & Tech Transfer April 3, 2026 35 min read Analyze GLP-1 drug manufacturing dynamics, detailing global capacity expansions, CDMO production strategies, and peptide synthesis tech transfer processes